Daiwa Securities Group
IMRX icon

Daiwa Securities Group’s Immuneering IMRX Stock Holding History

Daiwa Securities Group’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-76
Closed -$1K – 1354
2023
Q3 		$1K Hold
76
– – ﹤0.01% 1257
2023
Q2 		$1K Hold
76
– – ﹤0.01% 1278
2023
Q1 		$1K Hold
76
– – ﹤0.01% 1256
2022
Q4 		$0 Hold
76
– – ﹤0.01% 1341
2022
Q3 		$1K Hold
76
– – ﹤0.01% 1292
2022
Q2 		$0 Hold
76
– – ﹤0.01% 1389
2022
Q1 		$0 Hold
76
– – ﹤0.01% 1391
2021
Q4 		$1K Buy
+76
New +$1.85K ﹤0.01% 1339

Other funds holding IMRX

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return

Daiwa Securities Group's IMRX Position: Q4 2023 in Review

Daiwa Securities Group sold out of Immuneering (IMRX) in Q4 2023, closing a stake of 76 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in IMRX in Q4 2021 and held it in 8 quarters. The position peaked at $1K in Q3 2023. 52 funds tracked by Wall St. Rank hold IMRX as of Q4 2023.

  • Daiwa Securities Group reported no remaining Immuneering position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 76 Immuneering shares in Q4 2023, an estimated $1K.
  • Daiwa Securities Group first reported a position in Immuneering in Q4 2021 and held it in 8 quarters.
  • Daiwa Securities Group's Immuneering position peaked at $1K in Q3 2023.
  • 52 funds tracked by Wall St. Rank held Immuneering as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.